194 related articles for article (PubMed ID: 2110907)
1. Diabetes-related histopathologies of the rat retina prevented with an aldose reductase inhibitor.
Robison WG; Tillis TN; Laver N; Kinoshita JH
Exp Eye Res; 1990 Apr; 50(4):355-66. PubMed ID: 2110907
[TBL] [Abstract][Full Text] [Related]
2. Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor.
Robison WG; Nagata M; Laver N; Hohman TC; Kinoshita JH
Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2285-92. PubMed ID: 2509395
[TBL] [Abstract][Full Text] [Related]
3. Prevention of basement membrane thickening in retinal capillaries by a novel inhibitor of aldose reductase, tolrestat.
Robison WG; Kador PF; Akagi Y; Kinoshita JH; Gonzalez R; Dvornik D
Diabetes; 1986 Mar; 35(3):295-9. PubMed ID: 3081393
[TBL] [Abstract][Full Text] [Related]
4. Aldose reductase and pericyte-endothelial cell contacts in retina and optic nerve.
Robison WG; Nagata M; Tillis TN; Laver N; Kinoshita JH
Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2293-9. PubMed ID: 2509396
[TBL] [Abstract][Full Text] [Related]
5. Aldose reductase, diabetes, and thickening of the retinal inner limiting membrane.
Nagata M; Robison WG
Invest Ophthalmol Vis Sci; 1987 Nov; 28(11):1867-9. PubMed ID: 3117719
[TBL] [Abstract][Full Text] [Related]
6. Aldose reductase and retinal capillary basement membrane thickening.
Robison WG; Nagata M; Kinoshita JH
Exp Eye Res; 1988 Mar; 46(3):343-8. PubMed ID: 3127228
[TBL] [Abstract][Full Text] [Related]
7. The polyol pathway in retinal microangiopathy.
Robison WG; Kinoshita JH; Kador PF
Drugs; 1986; 32 Suppl 2():19-22. PubMed ID: 3098542
[TBL] [Abstract][Full Text] [Related]
8. Prevention of diabetes-related retinal microangiopathy with aldose reductase inhibitors.
Robison WG
Adv Exp Med Biol; 1988; 246():365-72. PubMed ID: 3150650
[TBL] [Abstract][Full Text] [Related]
9. Effects of aldose reductase inhibitor on retinal microangiopathy in streptozotocin-diabetic rats.
Kojima K; Matsubara H; Harada T; Mizuno K; Suzuki M; Hotta N; Kakuta H; Sakamoto N
Jpn J Ophthalmol; 1985; 29(1):99-109. PubMed ID: 3159927
[TBL] [Abstract][Full Text] [Related]
10. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors.
Kador PF; Akagi Y; Takahashi Y; Ikebe H; Wyman M; Kinoshita JH
Arch Ophthalmol; 1990 Sep; 108(9):1301-9. PubMed ID: 2119169
[TBL] [Abstract][Full Text] [Related]
11. Increases in collagen type IV and laminin in galactose-induced retinal capillary basement membrane thickening--prevention by an aldose reductase inhibitor.
Das A; Frank RN; Zhang NL; Samadani E
Exp Eye Res; 1990 Mar; 50(3):269-80. PubMed ID: 2108050
[TBL] [Abstract][Full Text] [Related]
12. Intervention with the aldose reductase inhibitor, tolrestat, in renal and retinal lesions of streptozotocin-diabetic rats.
McCaleb ML; McKean ML; Hohman TC; Laver N; Robison WG
Diabetologia; 1991 Oct; 34(10):695-701. PubMed ID: 1959701
[TBL] [Abstract][Full Text] [Related]
13. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia.
Frank RN; Amin R; Kennedy A; Hohman TC
Arch Ophthalmol; 1997 Aug; 115(8):1036-47. PubMed ID: 9258227
[TBL] [Abstract][Full Text] [Related]
14. Effect of aldose reductase inhibitors on the progression of retinopathy in galactose-fed dogs.
Akagi Y; Kador PF
Exp Eye Res; 1990 Jun; 50(6):635-9. PubMed ID: 2115453
[TBL] [Abstract][Full Text] [Related]
15. Aldose reductase activity and basement membrane thickening.
Frank RN
Metabolism; 1986 Apr; 35(4 Suppl 1):35-40. PubMed ID: 3083207
[TBL] [Abstract][Full Text] [Related]
16. Galactose-induced retinal microangiopathy in rats.
Kern TS; Engerman RL
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):490-6. PubMed ID: 7843917
[TBL] [Abstract][Full Text] [Related]
17. Retinal capillary dilation: early diabetic-like retinopathy in the galactose-fed rat model.
Glover JP; Jacot JL; Basso MD; Hohman TC; Robison WG
J Ocul Pharmacol Ther; 2000 Apr; 16(2):167-72. PubMed ID: 10803427
[TBL] [Abstract][Full Text] [Related]
18. [Prevention of pericyte ghost formation in retinal capillaries by aldose reductase inhibitor in galactose-fed dogs with diabetic retinopathy].
Akagi Y; Terubayashi H; Ikebe H; Kador PF; Kinoshita JH
Nippon Ganka Gakkai Zasshi; 1988 Sep; 92(9):1479-84. PubMed ID: 3145681
[No Abstract] [Full Text] [Related]
19. Prevention of pericyte ghost formation in retinal capillaries of galactose-fed dogs by aldose reductase inhibitors.
Kador PF; Akagi Y; Terubayashi H; Wyman M; Kinoshita JH
Arch Ophthalmol; 1988 Aug; 106(8):1099-102. PubMed ID: 3401138
[TBL] [Abstract][Full Text] [Related]
20. Diabetic-like retinopathy: early and late intervention therapies in galactose-fed rats.
Robison WG; Jacot JL; Glover JP; Basso MD; Hohman TC
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1933-41. PubMed ID: 9727416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
